Rojas-Morales, E.; Santos-López, G.; Hernández-Cabañas, S.; Arcega-Revilla, R.; Rosas-Murrieta, N.; Jasso-Miranda, C.; El-Kassis, E.G.; Reyes-Leyva, J.; Sedeño-Monge, V.
Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate. Int. J. Mol. Sci. 2020, 21, 218.
https://doi.org/10.3390/ijms21010218
AMA Style
Rojas-Morales E, Santos-López G, Hernández-Cabañas S, Arcega-Revilla R, Rosas-Murrieta N, Jasso-Miranda C, El-Kassis EG, Reyes-Leyva J, Sedeño-Monge V.
Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate. International Journal of Molecular Sciences. 2020; 21(1):218.
https://doi.org/10.3390/ijms21010218
Chicago/Turabian Style
Rojas-Morales, Emmanuel, Gerardo Santos-López, Samuel Hernández-Cabañas, Raúl Arcega-Revilla, Nora Rosas-Murrieta, Carolina Jasso-Miranda, Elie Girgis El-Kassis, Julio Reyes-Leyva, and Virginia Sedeño-Monge.
2020. "Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate" International Journal of Molecular Sciences 21, no. 1: 218.
https://doi.org/10.3390/ijms21010218
APA Style
Rojas-Morales, E., Santos-López, G., Hernández-Cabañas, S., Arcega-Revilla, R., Rosas-Murrieta, N., Jasso-Miranda, C., El-Kassis, E. G., Reyes-Leyva, J., & Sedeño-Monge, V.
(2020). Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate. International Journal of Molecular Sciences, 21(1), 218.
https://doi.org/10.3390/ijms21010218
